Skip to main content
PLOS One logoLink to PLOS One
. 2015 Aug 19;10(8):e0136368. doi: 10.1371/journal.pone.0136368

Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study

Sanne Christine van Kampen, Aigul Tursynbayeva, Aliya Koptleuova, Zauresh Murzakhmetova, Lyazzat Bigalieva, Moldir Aubakirova, Svetlana Pak, Susan van den Hof
PMCID: PMC4545753  PMID: 26287484

The fourth author's name is spelled incorrectly. The correct name is: Zauresh Murzakhmetova. The correct citation is: van Kampen SC, Tursynbayeva A, Koptleuova A, Murzakhmetova Z, Bigalieva L, Aubakirova M, et al. (2015) Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study. PLoS ONE 10(7): e0132514. doi:10.1371/journal.pone.0132514.

Reference

  • 1. van Kampen SC, Tursynbayeva A, Koptleuova A, Murzabekova Z, Bigalieva L, Aubakirova M, et al. (2015) Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study. PLoS ONE 10(7): e0132514 doi: 10.1371/journal.pone.0132514 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES